ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36125
-0.03%
Bitcoin
67,030.00
0.13%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pliant Therapeutics Inc (PLRX)

  7. Pliant Therapeutics Inc (PLRX) News

PLRX

Pliant Therapeutics (PLRX)

Pliant Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PLRX
DateTimeSourceHeadlineSymbolCompany
05/14/20246:43AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
05/14/20246:30AMGlobeNewswire Inc.Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
05/07/20247:00AMGlobeNewswire Inc.Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™NASDAQ:PLRXPliant Therapeutics Inc
05/06/20243:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLRXPliant Therapeutics Inc
05/06/20243:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
05/06/20243:05PMGlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
05/06/20245:02AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
05/01/20247:00AMGlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
04/02/20247:00AMGlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
03/27/20249:23AMGlobeNewswire Inc.Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International ConferenceNASDAQ:PLRXPliant Therapeutics Inc
03/12/20246:30AMGlobeNewswire Inc.Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
02/27/20243:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLRXPliant Therapeutics Inc
02/27/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
02/27/20243:03PMGlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
02/26/20247:00AMGlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:PLRXPliant Therapeutics Inc
02/14/20247:55PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PLRXPliant Therapeutics Inc
02/14/20247:52AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PLRXPliant Therapeutics Inc
02/07/20247:00AMGlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
02/05/20246:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
02/04/20242:29PMGlobeNewswire Inc.Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver FibrosisNASDAQ:PLRXPliant Therapeutics Inc
01/24/20243:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/24/20243:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/24/20243:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/24/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/19/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/19/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/19/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/03/20247:00AMGlobeNewswire Inc.Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PLRXPliant Therapeutics Inc
11/13/20233:30PMGlobeNewswire Inc.Pliant Therapeutics Presentations at The Liver Meeting® 2023 Highlight Bexotegrast, an Inhibitor of αvß6 and αvß1 Integrins, in Primary Sclerosing CholangitisNASDAQ:PLRXPliant Therapeutics Inc
11/09/20233:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PLRX

Your Recent History

HITB
SANTOSUSDT
FC Santos Fan Token
USOTC
JDEPF
JDE Peets NV (PK)
ASX
ORACD
Orora
NASDAQ
SJCCX
Steward Large Cap Core F...
LBNK
SHIB2USDT
Shib2.0
LSE
NUM
Numis
NASDAQ
FRYQMX
Innovative Financial and...
USOTC
SVTRF
Severn Trent (PK)
TSXV
TIM
Toachi Mining
TSXV
BCF
Builders Capital Mortgage
USOTC
HNLGY
Hang Lung (PK)
ASX
CAS
Crusader Resources
COIN
TKNBTC
BOV
CRIV4R
ALFA FINANC PN
NASDAQ
HAKI
Hall, Kinion & Associates
AMEX
SKN
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved